Check out the companies that make news after Tuesday’s bell:
Atlassian: Shares of Australian software company rose 1% over revised revenue guide for fiscal third quarter. Atlassian now expects revenues of between $ 566 million and $ 572 million. Analysts surveyed by FactSet previously forecast revenue of $ 487.2 million for the company’s third quarter. The new forecast is also above Atlassian’s previous revenue patterns for the quarter.
Stitch Fix: Personal style service shares fell 3.2% after the company announced that founder and CEO Katrina Lake would become chief executive and Elizabeth Spaulding would take over as CEO, starting in August 1st.
Endo International – The pharmaceutical company’s shares rose slightly after the company announced promising Phase 3 data on cellulite treatment in the official journal of the American Society of Dermatological Surgery. The data showed that treatment provided a clinically significant improvement in the onset of moderate to severe cellulite in the buttocks of adult women compared with placebo.
Amicus Therapeutics – The biopharmaceutical company’s shares rose 3% after Cantor Fitzgerald analysts updated the shares to overweight neutral, citing the company’s promising results from gene therapy.
Discovery: Discovery’s Class A and Class C shares fell 3.8% and 5.1%, respectively, after CNBC’s David Faber reported that Credit Suisse continues to unload positions in the media company as a result of the outbreak of Archegos Capital Management. Citing merchants, Credit Suisse sold 19 million of the media company’s Class A shares and 22 million in Class C shares.